Roselyne Delépine

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

P Colombat, A. Lemevel, P Bertrand et al. · Bone Marrow Transplantation · 2006 · 167 citations

Medicine, Oncology, Chemotherapy +11

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Emmanuel Gyan, Charles Foussard, Philippe B. Bertrand et al. · Blood · 2008 · 153 citations

Medicine, Hematology, Oncology +17

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial

Stéphane Leprêtre, Thérèse Aurran, Beatrice Mahé et al. · Blood · 2012 · 92 citations · Full text

Medicine, Oncology, Pharmacology +14

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse

Sophie Park, Nicolas Chapuis, F. Saint Marcoux et al. · Leukemia · 2013 · 59 citations

Medicine, Oncology, Pharmacology +14

Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial

Arnaud Pigneux, Marie C. Béné, L Salmi et al. · Journal of Clinical Oncology · 2018 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +15